Developer of mammalian cell engineering software designed to accelerate the design and manufacture of biologics and gene
Other Healthcare Technology Systems📍 Boston, MAFounded 2017
Current Valuation
$1.2B
as of 2023-Q1
UNICORN
Developer of mammalian cell engineering software designed to accelerate the design and manufacture of biologics and gene therapies.
Company Profile
Founded
2017
HQ
Boston, MA
Employees
116
Total Raised
$204.7M
Last Round
Series B — $175M (Jan 2023)
IPO Status
private
Fundraising Status
Series B · $175M · 3y 7mo ago
privateTotal raised $204.7M
Secondary Market
Implied price / share
$82
Last round price / share
$92.68
vs last round
-11.5%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q1. Refreshed quarterly.